XPH logo

XPH
SPDR Pharmaceuticals ETF

352
Volume
30,435.00
52W High
$57.24
52W Low
$35.22
50D MA
$50.86
Prev Close
$56.40
Loading...
Loading...
News
all
press releases
3 Undervalued ETFs to Buy Before 2026
Worried about high valuations? KBE, XRT, and XPH with low P/Es and fresh momentum are three undervalued ETFs to consider as 2026 approaches.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Pharma ETF (XPH) Hits a New 52-Week High
Pharma ETF XPH hits a fresh 52-week high as healthcare shines amid AI bubble fears and slowing growth. Biotech M&A adds fuel -- can momentum hold?
Zacks·4d ago
News Placeholder
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Sector ETF report for XPH
Zacks·15d ago
News Placeholder
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Smart Beta ETF report for XPH
Zacks·16d ago
News Placeholder
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.
Zacks·29d ago
News Placeholder
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio
Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.
Zacks·2mo ago
News Placeholder
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Zacks·3mo ago
News Placeholder
Trump To Issue 60-Day Warning Letters To Drugmakers Over Pricing
The U.S. President is expected to send out these letters through his social media platform, Truth Social.
Stocktwits·4mo ago
News Placeholder
ETFs on the Move Post U.S.-China Trade Deal
Zacks·7mo ago
News Placeholder
Morgan Stanley’s Wilson addresses 8 key investor questions
investing.com·7mo ago

Latest XPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.